Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intra-individual Cross-over Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/ Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors

NCT02034708 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.

NCT NCT02034708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02034708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intra-individual Cross-over Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/ Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors
Lead sponsor
Guerbet
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2014
Completion date
September 30, 2015
Enrollment
279 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

primary brain tumor